Shafique Virani, Chief Business Officer at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 60,000 shares at $13.74 ($764K) on 2023-07-18, disclosed to the SEC on 2023-07-19.
Scheduled sale ($764k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.72 | 30,000 | $352K | 46.0% |
| 2 | $13.74 | 30,000 | $412K | 54.0% |
| Total | $12.73 avg | 60,000 | $764K | 100% |
| Filing → |
| RXRX | SELL | 2023-11-17 | $117K | — | Filing → |
| RXRX | SELL | 2023-10-18 | $113K | — | Filing → |
| RXRX | SELL | 2023-09-19 | $156K | — | Filing → |